Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GnRH Analog”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01298960
What this trial is testing

Growth Hormone (GH) in in Vitro Fertilization (IVF) Poor-responder Patients

Who this might be right for
Complications; Artificial Fertilization, Introduction of Embryo in Embryo Transfer
Fundacion Dexeus 52
Not applicableStudy completedNCT06581679
What this trial is testing

Adenomyosis and Pregnancy: Levonorgestrel vs. GnRH for Blastocyst Transfer

Who this might be right for
Adenomyosis
Zagazig University 184
Not applicableStudy completedNCT03516110
What this trial is testing

Health Related Quality of Life and Multidimensional Evaluations of Prostate Cancer Subjects Aged ≥ 60 Years Initiating Gonadotropin-Releasing Hormone (GNRH) Agonist Therapy

Who this might be right for
Prostate Cancer
Ipsen 831
Large-scale testing (Phase 3)Study completedNCT04163458
What this trial is testing

Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)

Who this might be right for
Infertility
Ferring Pharmaceuticals 405
Not applicableStudy completedNCT02737800
What this trial is testing

Effect of Prolonged GnRh Agonists on Results of Intracytoplasmic Sperm Injection (ICSI ) in Endometrioma Patients

Who this might be right for
Endometrioma
Kasr El Aini Hospital 88
Not applicableStudy completedNCT01778452
What this trial is testing

Endometrial Genomic Profile in Endometrial Priming

Who this might be right for
Genomic Human Endometrial Expression Profile
Instituto Valenciano de Infertilidad, IVI VALENCIA 6
Post-approval studies (Phase 4)Study completedNCT00621179
What this trial is testing

Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF

Who this might be right for
EndometriosisInfertility
Colorado Center for Reproductive Medicine 37
Large-scale testing (Phase 3)Study completedNCT00664456
What this trial is testing

Luteinizing Hormone-Releasing Hormone Agonist Therapy and Iodine I 125 Implant in Treating Patients With Previously Untreated Prostate Cancer

Who this might be right for
Prostate Cancer
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 421
Early research (Phase 1)Study completedNCT00001259
What this trial is testing

A Treatment Study for Premenstrual Syndrome (PMS)

Who this might be right for
Premenstrual SyndromeMenstruation Disturbances
National Institute of Mental Health (NIMH) 60
Not applicableUnknownNCT01311037
What this trial is testing

The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer

Who this might be right for
Advanced Breast Cancer
King Faisal Specialist Hospital & Research Center 2
Not applicableStudy completedNCT02238366
What this trial is testing

Study To Assess Renewal Of Treatment In Patients Recently Diagnosed With Prostate Cancer

Who this might be right for
Prostate Cancer
Ipsen 368
Post-approval studies (Phase 4)Study completedNCT01769781
What this trial is testing

Anastrazole Plus GnRH-agonist in the Treatment of Endometriosis Recurrence

Who this might be right for
Endometriosis
Centre for Endocrinology and Reproductive Medicine, Italy 70
Post-approval studies (Phase 4)UnknownNCT04797338
What this trial is testing

Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

Who this might be right for
Pregnancy EarlyMiscarriageOvarian Hyperstimulation Syndrome
Assaf-Harofeh Medical Center 100
Post-approval studies (Phase 4)UnknownNCT02070198
What this trial is testing

Long Acting FSH Plus Antagonist Versus Daily FSH Plus Antagonist Versus Short Agonist Protocol in Poor Responders Undergoing IVF

Who this might be right for
Female InfertilityPoor Responder
Bioroma 120
Not applicableLooking for participantsNCT05567198
What this trial is testing

Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires

Who this might be right for
Systemic Lupus Erythematosus (Sle)Primary Ovarian Insufficiency (Poi)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 100
Early research (Phase 1)Not Yet RecruitingNCT07793162
What this trial is testing

A Phase Ia Trial Comparing the Pharmacokinetics/Pharmacodynamics, Safety, and Preliminary Efficacy of HHK001 and Enantone in Patients With Endometriosis

Who this might be right for
Endometriosis
The Third Xiangya Hospital of Central South University 20
Not applicableUnknownNCT02114645
What this trial is testing

The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes

Who this might be right for
Infertility
Zekai Tahir Burak Women's Health Research and Education Hospital 100
Not applicableEnded earlyNCT02677311
What this trial is testing

GnRHA Therapy and Ovarian Preservation in Pediatric Cancer Patient

Who this might be right for
CancerChemoradiation
University of Kentucky 2
Not applicableStudy completedNCT04600986
What this trial is testing

Repeated Doses of GnRH Agonist as Oocyte Triggering in Antagonist Protocol for Patients With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Royan Institute 70
Large-scale testing (Phase 3)Study completedNCT00003026
What this trial is testing

Hormone Therapy in Treating Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
European Organisation for Research and Treatment of Cancer - EORTC 966
Next Page